Chang, Alex H <br/><br/>
Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Oct 2008 
 - 1745-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2008.161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>DNA Modification Methylases--metabolism<br/>DNA Repair Enzymes--metabolism<br/>Factor IX--administration & dosage<br/>Genetic Vectors<br/>Hematopoietic Stem Cells--cytology<br/>Hemophilia B--therapy<br/>Homeostasis--drug effects<br/>Humans<br/>Lentivirus--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Recombinant Proteins--administration & dosage<br/>Tumor Suppressor Proteins--metabolism